Journal of Immunotherapy and Precision Oncology

EDITORIAL
Year
: 2019  |  Volume : 2  |  Issue : 3  |  Page : 53--54

Cancer immunotherapy for the immunosuppressed: Dissecting the conundrum of safety and efficacy


Joud Hajjar 
 Department of Pediatrics, Section of Immunology, Allergy, and Retrovirology, Baylor College of Medicine, The William T. Shearer Center for Human Immunobiology, Texas Children's Hospital, Houston, TX, USA

Correspondence Address:
Dr. Joud Hajjar
Baylor College of Medicine, Texas Children Hospital, Houston, TX
USA




How to cite this article:
Hajjar J. Cancer immunotherapy for the immunosuppressed: Dissecting the conundrum of safety and efficacy.J Immunother Precis Oncol 2019;2:53-54


How to cite this URL:
Hajjar J. Cancer immunotherapy for the immunosuppressed: Dissecting the conundrum of safety and efficacy. J Immunother Precis Oncol [serial online] 2019 [cited 2020 Apr 4 ];2:53-54
Available from: http://www.jipoonline.org/article.asp?issn=2666-2345;year=2019;volume=2;issue=3;spage=53;epage=54;aulast=Hajjar;type=0